Dr. Rubenstein is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
505 Parnassus Ave
San Francisco, CA 94143Phone+1 415-476-4029Fax+1 415-353-2765- Is this information wrong?
Education & Training
University of California (San Francisco)Fellowship, Hematology and Medical Oncology, 1994 - 1997
Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 1992 - 1995
Weill Cornell MedicineClass of 1992
Certifications & Licensure
CA State Medical License 1994 - 2025- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Primary CNS Lymphoma Start of enrollment: 2004 Oct 01
- A Safety Study of Rituximab Plus MTX Injected Into the Cerebrospinal Fluid in the Treatment of Brain Lymphoma Start of enrollment: 2007 Apr 01
- Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed Primary CNS Lymphoma Start of enrollment: 2003 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- 2 citationsEBV-positive PCNSL in older patients: incidence, characteristics, tumor pathology, and outcomes across a large multicenter cohort.Agrawal, P., David, K., Chen, Z., Sundaram, S., Kim, S., Vaca, R., Lin, Y., Singer, S., Malecek, M., Carter, J., Zayac, A., Kim, M., Reddy, N., Ney, D., Habib, A., Str...> ;Leukemia & Lymphoma. 2023 May 1
- 1 citationsTafasitamab at the blood-brain barrier.Andreas M Rauschecker, Shirley S Mo, Michael Randall, John Shen-Sampas, James L Rubenstein> ;British Journal of Haematology. 2023 Apr 1
- 1 citationsPrimary CNS lymphoma: update on molecular pathogenesis and therapy.Shirley S Mo, Joseph Cleveland, James L Rubenstein> ;Leukemia & Lymphoma. 2023 Jan 1
- Join now to see all
Abstracts/Posters
- Potential Genetic and Immunologic Mechanisms of Therapeutic Resistance and Disease Progression in CNS Lymphoma Elucidated Via Whole Brain Autopsy StudiesJames L. Rubenstein, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Lectures
- Understanding the Role of Autologous Transplant and Consolidation Strategies: Opinions and OptionsASCO Annual Meeting 2019 - Chicago, IL - 6/1/2019
Other
- AIDS-related lymphomas: Primary central nervous system lymphomaRubenstein JL, Kaplan LD
http://www.uptodate.com/contents/aids-related-lymphomas-primary-central-nervous-system-lymphoma
UpToDate, Wolters Kluwer Health - 2012-07-16
Press Mentions
Lenalidomide Highly Effective in Early Phase CNS Lymphoma StudyJune 20th, 2015
Grant Support
- The Role Of Interleukin-4 (Il-4) In The Pathogenesis Of Non-Hodgkin'S LymphomaNational Cancer Institute2009–2011
- Molecular Classification And Therapy Of CNS LymphomasNational Cancer Institute2004–2008
- Intrathecal Rituximab In Patients With Recurrent Lymphomatous MeningitisNational Center For Research Resources2004
Other Languages
- French
Hospital Affiliations
UCSF Medical CenterSan Francisco, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
